CA2729969A1 - Synthesis of 3,4-diaryl-4,5-dihydro-(1h)-pyrazole-1- carboxamidine derivatives - Google Patents

Synthesis of 3,4-diaryl-4,5-dihydro-(1h)-pyrazole-1- carboxamidine derivatives Download PDF

Info

Publication number
CA2729969A1
CA2729969A1 CA2729969A CA2729969A CA2729969A1 CA 2729969 A1 CA2729969 A1 CA 2729969A1 CA 2729969 A CA2729969 A CA 2729969A CA 2729969 A CA2729969 A CA 2729969A CA 2729969 A1 CA2729969 A1 CA 2729969A1
Authority
CA
Canada
Prior art keywords
formula
compound
alkyl
chosen
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2729969A
Other languages
English (en)
French (fr)
Inventor
Josephus H. M. Lange
Hans J. Sanders
Jeroen Van Rheenen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Healthcare Products BV
Original Assignee
Abbott Healthcare Products BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Healthcare Products BV filed Critical Abbott Healthcare Products BV
Publication of CA2729969A1 publication Critical patent/CA2729969A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2729969A 2008-08-01 2009-07-30 Synthesis of 3,4-diaryl-4,5-dihydro-(1h)-pyrazole-1- carboxamidine derivatives Abandoned CA2729969A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8547508P 2008-08-01 2008-08-01
EP08161619 2008-08-01
US61/085,475 2008-08-01
EP08161619.5 2008-08-01
PCT/EP2009/059844 WO2010012797A2 (en) 2008-08-01 2009-07-30 Synthesis of 3,4-diaryl-4,5-dihydro-(1h)-pyrazole-1- carboxamidine derivatives

Publications (1)

Publication Number Publication Date
CA2729969A1 true CA2729969A1 (en) 2010-02-04

Family

ID=40380031

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2729969A Abandoned CA2729969A1 (en) 2008-08-01 2009-07-30 Synthesis of 3,4-diaryl-4,5-dihydro-(1h)-pyrazole-1- carboxamidine derivatives

Country Status (12)

Country Link
EP (1) EP2321280A2 (es)
JP (1) JP2011529868A (es)
KR (1) KR20110042095A (es)
CN (1) CN102089284A (es)
AR (1) AR072539A1 (es)
AU (1) AU2009275838A1 (es)
BR (1) BRPI0916692A2 (es)
CA (1) CA2729969A1 (es)
EA (1) EA201170284A1 (es)
MX (1) MX2011001211A (es)
TW (1) TW201010981A (es)
WO (1) WO2010012797A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR079935A1 (es) * 2010-01-29 2012-02-29 Abbott Healthcare Products Bv Sintesis de derivados de pirazolin carboxamidina sustituida
US20220227714A1 (en) * 2019-05-17 2022-07-21 The United States Of America,As Represented By The Secretary,Department Of Health And Human Services A scalable synthesis of dual-target inhibitor of cannabinoid-1 receptor and inducible nitric oxide synthase
CN111686806B (zh) * 2020-05-29 2022-09-30 黑龙江大学 一种聚[2-(3-噻吩基)乙醇]/石墨相氮化碳复合可见光催化剂的制备方法及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5369121A (en) * 1990-01-31 1994-11-29 E. I. Du Pont De Nemours And Company Arthropodicidal pyrazolines, pyrazolidines and hydrazines
DE4005114A1 (de) * 1990-02-17 1991-08-22 Bayer Ag Substituierte pyrazolinderivate
ATE346047T1 (de) * 2000-03-23 2006-12-15 Solvay Pharm Bv 4,5-dihydro-1h-pyrazolderivate mit cb1- antagonistischer aktivität
UA77441C2 (en) * 2001-09-21 2006-12-15 4,5-dihydro-1h-pyrazole derivatives as potent cb1 receptor antagonists, methods for their preparation (variants), intermediate, pharmaceutical composition and method for its preparation

Also Published As

Publication number Publication date
EA201170284A1 (ru) 2011-06-30
WO2010012797A2 (en) 2010-02-04
EP2321280A2 (en) 2011-05-18
JP2011529868A (ja) 2011-12-15
CN102089284A (zh) 2011-06-08
BRPI0916692A2 (pt) 2016-05-17
WO2010012797A3 (en) 2010-04-22
MX2011001211A (es) 2011-03-29
TW201010981A (en) 2010-03-16
AR072539A1 (es) 2010-09-01
AU2009275838A1 (en) 2010-02-04
KR20110042095A (ko) 2011-04-22

Similar Documents

Publication Publication Date Title
US7608718B2 (en) 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
TWI283667B (en) Selective synthesis of CF3-substituted pyrimidines
KR20150041650A (ko) (ｓ)-3-(4-((4-(모르폴리노메틸)벤질)옥시)-1-옥소이소인돌린-2-일)피페리딘-2,6-디온 및 이의 약학적으로 허용가능한 형태의 제조를 위한 공정
US20080058543A1 (en) Process for making chiral 1,4-disubstituted piperazines
CA2729969A1 (en) Synthesis of 3,4-diaryl-4,5-dihydro-(1h)-pyrazole-1- carboxamidine derivatives
JP2010111684A (ja) キラル２−メチル−４−保護化ピペラジンの立体選択的アルキル化
US20110137040A1 (en) Synthesis of 3,4-diaryl-4,5-dihydro-(h)-pyrazole-1-carboxamidine derivatives
US20090264648A1 (en) Synthesis of pyrazoles
EP2528900B1 (en) Synthesis of substituted pyrazoline carboxamidine derivatives
KR20140027921A (ko) 디(아릴아미노)아릴 화합물의 제조 방법 및 그 합성 중간체
CN111868031A (zh) N-烷氧基羰基哌啶衍生物的制备方法及其中间体
JP2004250340A (ja) ４−ヒドラジノテトラヒドロピラン化合物又はその酸塩の製法
EP2103596A1 (en) Process for the preparation of N-(phenylethyl) anilines salts and solvates thereof useful as serotonin 5-HT6 antagonists
JP2000186081A (ja) メチルアミン誘導体の製造法

Legal Events

Date Code Title Description
FZDE Discontinued